Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Resistant Major Depression Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT01613820
What this trial is testing

Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Massachusetts General Hospital
Post-approval studies (Phase 4)Looking for participantsNCT06748209
What this trial is testing

Establishing Mobile Transcranial Magnetic Stimulation

Who this might be right for
Treatment Resistant Major Depression
Medical University of South Carolina 30
Post-approval studies (Phase 4)Ended earlyNCT00296686
What this trial is testing

Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression

Who this might be right for
Major Depression
New York State Psychiatric Institute 31
Early research (Phase 1)Looking for participantsNCT03973268
What this trial is testing

Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

Who this might be right for
DepressionMajor Depressive DisorderMajor Depression
National Institute of Mental Health (NIMH) 70
Not applicableLooking for participantsNCT04124341
What this trial is testing

PCS in Severe Treatment Resistant Depression

Who this might be right for
Treatment Resistant Depression
University of Minnesota 15
Not applicableLooking for participantsNCT06773949
What this trial is testing

Feasibility Trial of Exercise as a Priming Strategy for rTMS Treatment in Difficult-to-Treat Depression

Who this might be right for
Major Depressive Disorder (MDD)Treatment Resistant Depression (TRD)
The Royal Ottawa Mental Health Centre 20
Not applicableStudy completedNCT01515215
What this trial is testing

Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depressive Disorder

Who this might be right for
Major Depressive Disorder
Centre for Addiction and Mental Health 107
Testing effectiveness (Phase 2)Study completedNCT01428804
What this trial is testing

Study of Transcranial Direct Current Stimulation (tDCS) as add-on Treatment for Resistant Major Depression

Who this might be right for
Resistant Major Depression
Centre Hospitalier Universitaire de Besancon 24
Very early researchStudy completedNCT04977674
What this trial is testing

Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine

Who this might be right for
Depressive Disorder, Treatment-Resistant
King's College London 27
Not applicableLooking for participantsNCT05773755
What this trial is testing

DBS for TRD With the Medtronic Percept PC

Who this might be right for
Major Depressive DisorderTreatment Resistant Depression
Helen Mayberg, MD 20
Not applicableStudy completedNCT04101474
What this trial is testing

Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality

Who this might be right for
Treatment Resistant Depression
Assiut University 36
Not applicableNot Yet RecruitingNCT07529574
What this trial is testing

Efficacy and Safety of a Theta Burst Stimulation Protocol of Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder (MDD)Depression - Major Depressive Disorder
Jung-Sun Lee 120
Large-scale testing (Phase 3)Study completedNCT03113968
What this trial is testing

ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)

Who this might be right for
Treatment Resistant DepressionElectroconvulsive TherapyECT+6 more
Bo Hu 403
Not applicableUnknownNCT05422417
What this trial is testing

Dorsomedial Prefrontal Neuromodulation in Treatment-resistant Depression

Who this might be right for
Treatment-resistant DepressionMajor Depressive Disorder
Taipei Veterans General Hospital, Taiwan 75
Large-scale testing (Phase 3)Study completedNCT02741791
What this trial is testing

Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder

Who this might be right for
Treatment Resistant Major Depressive Disorder
Axsome Therapeutics, Inc. 312
Large-scale testing (Phase 3)UnknownNCT02037503
What this trial is testing

The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major Depression

Who this might be right for
Suicidal IdeationMajor Depressive DisorderHealthy Participants
Tel-Aviv Sourasky Medical Center 100
Not applicableLooking for participantsNCT07740694
What this trial is testing

EEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECT

Who this might be right for
Major Depression ModerateMajor Depression SevereMajor Depression With Comorbid Anxiety Symptoms+8 more
Istanbul University - Cerrahpasa 62
Testing effectiveness (Phase 2)Study completedNCT05454410
What this trial is testing

Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD)

Who this might be right for
Treatment-Resistant Depression
Novartis Pharmaceuticals 60
Not applicableEnded earlyNCT03254017
What this trial is testing

Remotely Programmed Deep Brain Stimulation of the Bilateral Habenula for Treatment- Resistant Major Depression: An Open Label Pilot Trial

Who this might be right for
Treatment Resistant Major Depressive Disorder
Ruijin Hospital 2
Testing effectiveness (Phase 2)Study completedNCT03756129
What this trial is testing

Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression

Who this might be right for
Depressive Disorder, Treatment-Resistant
Novartis Pharmaceuticals 70
Next Page